- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02577237
Building Caregiver Skills Using a Simulation-based Intervention for Care of Head and Neck Cancer
Building Family Caregiver Skills Using a Simulation-based Intervention for Care of Patients With Head and Neck Cancer
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Aim 1: Conduct a pilot test of the effects of a novel caregiver intervention, as compared to a control group, on family caregiver self-efficacy for caregiving, anxiety, depression, and health-related quality of life.
Aim 2: Explore the acceptability of a caregiver intervention that utilizes simulation.
Aim 3: Assess the feasibility of the intervention. Aim 4: Describe the incidence of patient events that may be impacted by caregiver self-efficacy, such as acute care visits, admissions to the hospital, visits to the emergency department, need for fluids in the radiation oncology department, and interrupted treatment course.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Ohio
-
Cleveland, Ohio, Forenede Stater, 44106
- University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- family member or friend of an adult patient with a new diagnosis of Stage III - IV cancers of the tongue, gum, oral cavity, nasopharynx, oropharynx, hypopharynx, larynx, or parotid who is receiving radiation therapy for curative intent
- identified by the patient as his/her primary caregiver who is providing daily assistance and/or emotional support
- cognitively intact, as evidenced by orientation to person, place, and time
- ability to speak, read, and comprehend English
Exclusion Criteria:
- Caregivers of patients who are receiving hospice care will be excluded because of the patient's poor prognosis and multiple issues associated with end-of-life care
- Caregivers who are themselves undergoing active cancer treatment will be excluded (hormonal treatment allowed)
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Eksperimentel: Intervention Group: Caregiver education
The intervention includes caregivers who will receive an education and support program throughout radiation treatment in addition to usual care by their doctors and nurses.
|
The intervention will be delivered by a radiation oncology nurse.
Each of the four in-person sessions consists of approximately 30 minutes of educational content/simulation that addresses a specific caregiving topic and any issues or concerns that the caregiver may be experiencing.
Andre navne:
written, qualitative assessments of areas including depression and anxiety, caregiver self-efficacy, care-giver self efficacy for head and neck cancer, health-related quality of life, patient performance status, demographics, and medical history.
A structured series of open-ended questions will be used during a telephone interview with participants at four weeks post radiation treatment.
Andre navne:
|
Aktiv komparator: Control Group: educational booklet
The control group will receive an educational booklet about caregiving in addition to usual care by their doctors and nurses
|
written, qualitative assessments of areas including depression and anxiety, caregiver self-efficacy, care-giver self efficacy for head and neck cancer, health-related quality of life, patient performance status, demographics, and medical history.
A structured series of open-ended questions will be used during a telephone interview with participants at four weeks post radiation treatment.
Andre navne:
Radiation Oncology Nurse will hand participant the NCI booklet
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Average efficacy of caregiving summary score
Tidsramme: Up to 5 weeks
|
Summary statistics as well as observed values of longitudinally measured efficacy outcome variables (efficacy for caregiving, anxiety, depression, and HRQOL) will be presented graphically.
Linear mixed models will be used to estimate within- and between-subject components of variance needed for design of a larger trial with these endpoints.
|
Up to 5 weeks
|
Average anxiety summary score
Tidsramme: Up to 5 weeks
|
Summary statistics as well as observed values of longitudinally measured efficacy outcome variables (efficacy for caregiving, anxiety, depression, and HRQOL) will be presented graphically.
Linear mixed models will be used to estimate within- and between-subject components of variance needed for design of a larger trial with these endpoints.
|
Up to 5 weeks
|
Average depression summary score
Tidsramme: Up to 5 weeks
|
Summary statistics as well as observed values of longitudinally measured efficacy outcome variables (efficacy for caregiving, anxiety, depression, and HRQOL) will be presented graphically.
Linear mixed models will be used to estimate within- and between-subject components of variance needed for design of a larger trial with these endpoints.
|
Up to 5 weeks
|
Average Health Related Quality of Life (HRQOL) summary score
Tidsramme: Up to 5 weeks
|
Summary statistics as well as observed values of longitudinally measured efficacy outcome variables (efficacy for caregiving, anxiety, depression, and HRQOL) will be presented graphically.
Linear mixed models will be used to estimate within- and between-subject components of variance needed for design of a larger trial with these endpoints.
|
Up to 5 weeks
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Qualitative assessment of acceptability
Tidsramme: Up to 5 weeks
|
Descriptive statistics will be used to summarize responses to semi-structured interviews
|
Up to 5 weeks
|
Attrition rate to assess feasibility
Tidsramme: Up to 5 weeks
|
Feasibility will be assessed via attrition and consent rates.
|
Up to 5 weeks
|
Consent rate to assess feasibility
Tidsramme: Up to 5 weeks
|
Feasibility will be assessed via attrition and consent rates.
|
Up to 5 weeks
|
Total time for delivering intervention to assess costs
Tidsramme: Up to 5 weeks
|
Time for delivering the intervention will be recorded to aid in assessing costs.
|
Up to 5 weeks
|
Average missed checklist items to assess integrity of intervention
Tidsramme: Up to 5 weeks
|
Integrity of the intervention will be assessed through monitoring of intervention checklist.
|
Up to 5 weeks
|
Event rate for patient events
Tidsramme: Up to 5 weeks
|
Describe the average incidence of all patient events that may be impacted by caregiver self-efficacy.
Events may include acute care visits, admission to the hospital, visits to the emergency department, need for fluids in the radiation oncology department, and interrupted treatment course, and others
|
Up to 5 weeks
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Susan Mazanec, PhD, RN, University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- CASE2315
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med In-person education sessions
-
Northwestern UniversityNational Institutes of Health (NIH); Alzheimer's Association; Illinois Department... og andre samarbejdspartnereAfsluttetFrontotemporal demens | Primær progressiv afasiForenede Stater
-
Istituti Clinici Scientifici Maugeri SpATrukket tilbage
-
University of Colorado, DenverAfsluttet
-
Washington University School of MedicineAfsluttetPolyfarmaci | Medicinsk manglende overholdelseForenede Stater
-
University of WashingtonCenters for Disease Control and PreventionRekrutteringGigt | Slidgigt | Rheumatoid arthritis | Fibromyalgi | Gigt | Lupus eller SLEForenede Stater
-
Abramson Cancer Center at Penn MedicineUnited States Department of DefenseIkke rekrutterer endnuLymfødem i hoved og halsForenede Stater
-
Matthew Bush, MDAfsluttetHøretab | HørelidelserForenede Stater
-
Brandon HathornBaylor Heart and Vascular Institute Cardiovascular Research Review CommitteeAfsluttetKoronararteriesygdom | Ventilsygdom, hjerte
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI); Healthways, Inc.Afsluttet
-
Johns Hopkins UniversityAmerican SIDS InstituteIkke rekrutterer endnuPludselig spædbarnsdød